
Actinic keratosis is a chronic skin disease and one of the most common diagnoses in dermatology practices in Europe

The new centre will be home to nearly 2,000 world-class researchers and scientists

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

The agreement will improve access to twice-yearly Lenacapavir across Latin America and the Caribbean

The results from a global phase 3 trial show the longest survival data ever reported in this setting

The centre in California supports the company’s $32bn US investment

This is the first new regimen in more than a decade for first-line treatment for this type of breast cancer

The treatments are for eligible adults in England and Wales

The treatment is for cerebral adrenoleukodystrophy, a rare neurodegenerative disease

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood